Source link : https://www.newshealth.biz/health-news/studies-point-to-several-options-for-ulcerative-colitis-after-anti-tnf-failure/
(MedPage Today) — SAN FRANCISCO — Research presented at the annual Crohn’s and Colitis Congress included studies comparing the effectiveness of vedolizumab (Entyvio) versus ustekinumab (Stelara) and of each biologic against Janus kinase (JAK… Source link : https://www.medpagetoday.com/meetingcoverage/ccc/114186 Author : Publish date : 2025-02-12 15:45:58 Copyright for syndicated content belongs to the linked Source.
Author : News Health
Publish date : 2025-02-12 15:45:58
Copyright for syndicated content belongs to the linked Source.